The Israel Ministry of Health (MoH), Pfizer, and BioNTech recently shared real-world evidence showing that the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, elicited lower incidence rates of coronavirus...
The Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) recently reaffirmed the benefits of AstraZeneca’s COVID-19 vaccine.
The agencies stated that...
In an official letter to President Joe Biden, PhRMA and over 30 leaders in the biopharmaceutical warned that eliminating intellectual property (IP) protections in COVID-19 vaccine development could...
Researchers recently developed a promising new blueprint for an RNA-based vaccine for malaria, which contains similar properties as the novel RNA COVID-19 vaccines.
Novartis Pharmaceutical and...
GE Research and a multi-disciplinary team are receiving up to $41 million over the next five years to boost nucleic acid-based vaccine manufacturing and distribution.
The Defense Advanced...
The Biden Administration recently announced a historic collaboration between Johnson & Johnson and Merck to expand production of Johnson & Johnson’s COVID-19 vaccine,...
AstraZeneca recently announced that the first doses of its COVID-19 vaccine through the COVAX initiative have begun arriving in low and middle-income countries globally.
The first shipments were...
Johnson & Johnson recently announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended its single-shot COVID-19 vaccine under the recent FDA emergency use...
Moderna recently announced that it has shipped doses of its variant-specific COVID-19 vaccine candidate to the National Institutes of Health (NIH) for a Phase 1 clinical trial.
NIAID will conduct the...
Pfizer and BioNTech recently announced the submission of new data to FDA demonstrating the stability of their COVID-19 vaccine when stored at higher temperatures.
Specifically, the...
Moderna recently announced that it is making new capital investments to increase global manufacturing capacity of its COVID-19 vaccine, mRNA-1273.
The company will make investments to increase...
Pfizer and BioNTech recently announced that the first participants have been dosed in a global Phase 2/3 study to further evaluate their COVID-19 vaccine in healthy pregnant women.
The randomized,...
FDA recently issued three guidance documents for COVID-19 vaccine developers and other medical product creators covering to address the current and potential future emergence of variants of...
FDA has issued an emergency use authorization for a third COVID-19 vaccine to Johnson & Johnson, which will be distributed in the US for use in individuals 18 years of age and older.
The...
Promise of the world returning to normal hinges on COVID-19 vaccine rollout. Talk of herd immunity has given people hope that large gatherings, indoor dining, and sporting events will once again become a part of everyday life, or at least...
A recent FDA analysis found that Johnson & Johnson’s COVID-19 vaccine met requirements for emergency use authorization.
The data submitted to FDA by the pharmaceutical company was from...
GSK recently announced that the first patient has been dosed in a Phase 3 clinical program investigating the immunogenicity, safety, and reactogenicity of a RSV vaccine candidate for older...
HHS and the Department of Defense (DoD) recently purchased an additional 100 million doses of COVID-19 vaccines from both Pfizer and Moderna to boost vaccine supply in the US.
The recent order brings...
HHS recently announced new actions to expand COVID-19 testing capacity across the US as part of President Joe Biden’s National Strategy for the COVID-19 Response and Pandemic Preparedness.
The...
The World Health Organization (WHO) recently granted AstraZeneca’s COVID-19 vaccine emergency use listing (EUL) for active immunization to prevent coronavirus in individuals 18 years of age and...
